Literature DB >> 21613514

The influence of PKA treatment on the Ca2+ activation of force generation by trout cardiac muscle.

Todd E Gillis1, Jordan M Klaiman.   

Abstract

β-Adrenergic stimulation of the mammalian heart increases heart rate, the strength of contraction as well as the kinetics of force generation and relaxation. These effects are due to the phosphorylation of select membrane and thin filament proteins by cAMP-activated protein kinase (PKA). At the level of the sarcomere, it is typically the phosphorylation of cardiac myosin binding protein C (cMyBP-C) and cardiac troponin I (cTnI) that is responsible for the change in the kinetics of contraction and relaxation. Trout cTnI (ScTnI) lacks two critical PKA targets within the N-terminus of the protein that, when phosphorylated in mammalian cTnI, cause a reduction in myofilament Ca(2+) affinity. To determine what role the contractile element plays in the response of the trout heart to β-adrenergic stimulation, we characterized the influence of PKA treatment on the Ca(2+) activation of skinned preparations dissected from ventricular trabeculae. In these experiments, isometric force generation and the rate of force development were measured over a range of Ca(2+) concentrations. The results demonstrate that PKA treatment does not influence the Ca(2+) sensitivity of force generation but it decreases maximum force generation by 25% and the rate of force re-development at maximal activation by 46%. Analysis of the trabeculae preparations for phosphoproteins revealed that PKA treatment phosphorylated myosin light chain 2 but not cTnI or cMyBP-C. These results indicate that the function of the trout cardiac contractile element is altered by PKA phosphorylation but in a manner different from that in mammalian heart.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21613514     DOI: 10.1242/jeb.052084

Source DB:  PubMed          Journal:  J Exp Biol        ISSN: 0022-0949            Impact factor:   3.312


  7 in total

1.  Characterizing the influence of chronic hypobaric hypoxia on diaphragmatic myofilament contractile function and phosphorylation in high-altitude deer mice and low-altitude white-footed mice.

Authors:  Y Ding; S A Lyons; G R Scott; Todd E Gillis
Journal:  J Comp Physiol B       Date:  2019-07-05       Impact factor: 2.200

2.  Evolution of the N-Terminal Regulation of Cardiac Troponin I for Heart Function of Tetrapods: Lungfish Presents an Example of the Emergence of Novel Submolecular Structure to Lead the Capacity of Adaptation.

Authors:  Monica Rasmussen; Han-Zhong Feng; J-P Jin
Journal:  J Mol Evol       Date:  2021-12-29       Impact factor: 2.395

3.  Species- and chamber-specific responses of 12 kDa FK506-binding protein to temperature in fish heart.

Authors:  Hanna Korajoki; Matti Vornanen
Journal:  Fish Physiol Biochem       Date:  2013-09-19       Impact factor: 2.794

4.  Characterization of the functional and anatomical differences in the atrial and ventricular myocardium from three species of elasmobranch fishes: smooth dogfish (Mustelus canis), sandbar shark (Carcharhinus plumbeus), and clearnose skate (Raja eglanteria).

Authors:  Julie Larsen; Peter Bushnell; John Steffensen; Morten Pedersen; Klaus Qvortrup; Richard Brill
Journal:  J Comp Physiol B       Date:  2016-09-29       Impact factor: 2.200

5.  Cardiac remodeling in fish: strategies to maintain heart function during temperature Change.

Authors:  Jordan M Klaiman; Andrew J Fenna; Holly A Shiels; Joseph Macri; Todd E Gillis
Journal:  PLoS One       Date:  2011-09-07       Impact factor: 3.240

Review 6.  Temperature-induced cardiac remodelling in fish.

Authors:  Adam N Keen; Jordan M Klaiman; Holly A Shiels; Todd E Gillis
Journal:  J Exp Biol       Date:  2016-11-16       Impact factor: 3.312

Review 7.  Functional and structural differences between skinned and intact muscle preparations.

Authors:  Alex Lewalle; Kenneth S Campbell; Stuart G Campbell; Gregory N Milburn; Steven A Niederer
Journal:  J Gen Physiol       Date:  2022-01-19       Impact factor: 4.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.